De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma.
从头合成丝氨酸是一种代谢弱点，可以利用这种弱点来克服晚期肾细胞癌的舒尼替尼耐药性
期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-24-1393
Teisseire Manon, Sahu Umakant, Parola Julien, Tsai Meng-Chen, Vial Valérie, Durivault Jérôme, Grépin Renaud, Cormerais Yann, Molina Clément, Gouraud Arthur, Pagès Gilles, Ben-Sahra Issam, Giuliano Sandy
